Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2014 | 1 |
2019 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence.
J Thromb Thrombolysis. 2023 Apr;55(3):449-463. doi: 10.1007/s11239-023-02776-z. Epub 2023 Feb 6.
J Thromb Thrombolysis. 2023.
PMID: 36746885
Free PMC article.
Review.
Design of human granzyme B variants resistant to serpin B9.
Losasso V, Schiffer S, Barth S, Carloni P.
Losasso V, et al. Among authors: schiffer s.
Proteins. 2012 Nov;80(11):2514-22. doi: 10.1002/prot.24133. Epub 2012 Jul 31.
Proteins. 2012.
PMID: 22733450
Item in Clipboard
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial.
Kirchhof P, Ezekowitz MD, Purmah Y, Schiffer S, Meng IL, Camm AJ, Hohnloser SH, Schulz A, Wosnitza M, Cappato R.
Kirchhof P, et al. Among authors: schiffer s.
TH Open. 2020 Jan 23;4(1):e20-e32. doi: 10.1055/s-0040-1701206. eCollection 2020 Jan.
TH Open. 2020.
PMID: 31984306
Free PMC article.
Item in Clipboard
BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics.
Thomas D, Thelen K, Kraff S, Schwers S, Schiffer S, Unger S, Yassen A, Boxnick S.
Thomas D, et al. Among authors: schiffer s.
Res Pract Thromb Haemost. 2019 Feb 14;3(2):242-253. doi: 10.1002/rth2.12186. eCollection 2019 Apr.
Res Pract Thromb Haemost. 2019.
PMID: 31011708
Free PMC article.
Item in Clipboard
Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
Schiffer S, Letzian S, Jost E, Mladenov R, Hristodorov D, Huhn M, Fischer R, Barth S, Thepen T.
Schiffer S, et al.
Cancer Lett. 2013 Dec 1;341(2):178-85. doi: 10.1016/j.canlet.2013.08.005. Epub 2013 Aug 22.
Cancer Lett. 2013.
PMID: 23973499
Item in Clipboard
Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.
Schiffer S, Rosinke R, Jost E, Hehmann-Titt G, Huhn M, Melmer G, Barth S, Thepen T.
Schiffer S, et al.
Int J Cancer. 2014 Sep 15;135(6):1497-508. doi: 10.1002/ijc.28786. Epub 2014 Mar 18.
Int J Cancer. 2014.
PMID: 24523193
Free article.
Item in Clipboard
Cite
Cite